James D. Douketis

22.8k total citations · 7 hit papers
238 papers, 13.2k citations indexed

About

James D. Douketis is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, James D. Douketis has authored 238 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Cardiology and Cardiovascular Medicine, 171 papers in Internal Medicine and 40 papers in Surgery. Recurrent topics in James D. Douketis's work include Venous Thromboembolism Diagnosis and Management (171 papers), Atrial Fibrillation Management and Outcomes (154 papers) and Antiplatelet Therapy and Cardiovascular Diseases (63 papers). James D. Douketis is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (171 papers), Atrial Fibrillation Management and Outcomes (154 papers) and Antiplatelet Therapy and Cardiovascular Diseases (63 papers). James D. Douketis collaborates with scholars based in Canada, United States and Italy. James D. Douketis's co-authors include Alex C. Spyropoulos, John W. Eikelboom, Andrew Dunn, P. Choi, Wendy Lim, Mark Crowther, Amir K. Jaffer, Lori‐Ann Linkins, Jeffrey S. Ginsberg and Frederick A. Spencer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

James D. Douketis

230 papers receiving 12.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Management of Antithrombotic Therapy

2012 1.1k citations James D. Douketis, Alex C. Spyropoulos et al. profile →
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.

2003 570 citations James D. Douketis et al. profile →
The Perioperative Management of Antithrombotic Therapy

2008 554 citations James D. Douketis, Alex C. Spyropoulos et al. profile →
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19

2020 440 citations Alex C. Spyropoulos, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

2012 399 citations Jeff S. Healey, John W. Eikelboom et al. Circulation profile →
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

2016 249 citations James D. Douketis et al. profile →
Perioperative Management of Antithrombotic Therapy

2022 146 citations James D. Douketis, Alex C. Spyropoulos et al. profile →

Peers

Countries citing papers authored by James D. Douketis

Since Specialization

Citations

This map shows the geographic impact of James D. Douketis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Douketis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Douketis more than expected).

Fields of papers citing papers by James D. Douketis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Douketis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Douketis. The network helps show where James D. Douketis may publish in the future.

Co-authorship network of co-authors of James D. Douketis

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Douketis. A scholar is included among the top collaborators of James D. Douketis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Douketis. James D. Douketis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure 2024 ·Blood Advances ·(unknown), Kevin Dwyer, Daniel I. McIsaac, Manish M. Sood, Edward G. Clark, James D. Douketis, Marc Carrier, Joseph R. Shaw	0
2	Anticoagulation Stewardship to Bridge the Implementation Gap in Perioperative Anticoagulation Management 2024 ·SHILAP Revista de lepidopterología ·Alfonso Tafur, Geoffrey D. Barnes, Vinai Bhagirath, James D. Douketis	1
3	Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH 2024 ·Journal of Thrombosis and Haemostasis ·Jerrold H. Levy, Joseph R. Shaw, Lana A. Castellucci, Jean M. Connors, James D. Douketis, Edelgard Lindhoff‐Last, Bianca Rocca, Charles Marc Samama, Deborah Siegal, Jeffrey I. Weitz	17
4	Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time? 2024 ·European Journal of Internal Medicine ·(unknown), (unknown), James D. Douketis	1
5	Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review 2023 ·Research and Practice in Thrombosis and Haemostasis ·Matteo Candeloro, (unknown), (unknown), James D. Douketis	12
6	Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer 2023 ·Journal of Thrombosis and Haemostasis ·Joseph R. Shaw, Na Li, (unknown), Steffan Frosi Stella, (unknown), (unknown), Alex C. Spyropoulos, Sam Schulman, Tzu‐Fei Wang, Marc Carrier, James D. Douketis	2
7	Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Tzu‐Fei Wang, Deborah Siegal, James D. Douketis, Grégoire Le Gal, Marc Carrier, Joseph R. Shaw	2
8	Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis 2023 ·Journal of Thrombosis and Haemostasis ·Jerrold H. Levy, Roman M. Sniecinski, Bianca Rocca, Kamrouz Ghadimi, James D. Douketis, Corinne Frère, Julie Helms, Toshiaki Iba, Andreas Koster, (unknown), Cheryl L. Maier, M. Neal, (unknown), Alex C. Spyropoulos, Marie E. Steiner, Alfonso Tafur, Kenichi A. Tanaka, Jean M. Connors	15
9	Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH 2022 ·Journal of Thrombosis and Haemostasis ·Tzu‐Fei Wang, Kristen M. Sanfilippo, James D. Douketis, Anna Falanga, (unknown), Anthony Maraveyas, Thomas L. Ortel, Gerald A. Soff, Suresh Vedantham, Jeffrey I. Zwicker	7
10	Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis 2022 ·SHILAP Revista de lepidopterología ·Sahrish Shah, Meritxell Urtecho, Mohammed Firwana, Tarek Nayfeh, Bashar Hasan, (unknown), Samer Saadi, (unknown), Rami Abd‐Rabu, Mohamed O. Seisa, (unknown), Leslie C. Hassett, Alex C. Spyropoulos, James D. Douketis, M. Hassan Murad	17
11	Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials 2022 ·Journal of Clinical Medicine ·Konstantinos G. Kyriakoulis, Evangelos Dimakakos, (unknown), M. Catalano, Alex C. Spyropoulos, Sam Schulman, James D. Douketis, Anna Falanga, Anthony Maraveyas, Dan-Mircea Olinic, J. J. F. Belch, Grigoris Gerotziafas, Konstantinos Syrigos, Αναστάσιος Κόλλιας	10
12	Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH 2022 ·Journal of Thrombosis and Haemostasis ·Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, Mark Goldin, Beverley J. Hunt, Taiwo R. Kotila, Renato D. Lópes, Sam Schulman, (unknown)	24
13	Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis 2020 ·Research and Practice in Thrombosis and Haemostasis ·Joseph R. Shaw, Tinghua Zhang, Grégoire Le Gal, James D. Douketis, Marc Carrier	6
14	Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study 2020 ·Journal of the American Heart Association ·Alfonso Tafur, Nathan P. Clark, Alex C. Spyropoulos, Na Li, Eric Kaplovitch, (unknown), Sam Schulman, Joseph A. Caprini, James D. Douketis	31
15	Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 breakdown → 2020 ·Journal of Thrombosis and Haemostasis ·Alex C. Spyropoulos, Jerrold H. Levy, Walter Ageno, Jean M. Connors, Beverley J. Hunt, Toshiaki Iba, Marcel Levi, Charles Marc Samama, Jecko Thachil, Dimitrios Giannis, James D. Douketis	440
16	Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH 2020 ·Journal of Thrombosis and Haemostasis ·Tzu‐Fei Wang, Robert S. Makar, Darko Antić, Jerrold H. Levy, James D. Douketis, Jean M. Connors, Marc Carrier, Jeffrey I. Zwicker	19
17	“Pharmacist-led group” 2014 ·Canadian Medical Association Journal ·James D. Douketis, Marc Carrier, Mark Crowther, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
18	Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin breakdown → 2012 ·Circulation ·Jeff S. Healey, John W. Eikelboom, James D. Douketis, Lars Wallentin, Jonas Oldgren, Sean Yang, Ellison Themeles, Hein Heidbüchel, Álvaro Avezum, Paul Reilly, Stuart J. Connolly, Salim Yusuf, Michael D. Ezekowitz	399
19	Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin? 2007 ·The American Journal of Medicine ·James D. Douketis, Magda Melo, Chaim M. Bell, Muhammad Mamdani	56
20	Opinions in pediatric and adolescent gynecology 2003 ·Journal of Pediatric and Adolescent Gynecology ·James D. Douketis, Anthony K.C. Chan, Patricia Massicotte	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact